Page last updated: 2024-10-18

dalteparin and Acidosis, Renal Tubular Type IV

dalteparin has been researched along with Acidosis, Renal Tubular Type IV in 1 studies

Dalteparin: A low-molecular-weight fragment of heparin, prepared by nitrous acid depolymerization of porcine mucosal heparin. The mean molecular weight is 4000-6000 daltons. It is used therapeutically as an antithrombotic agent. (From Merck Index, 11th ed)

Research Excerpts

ExcerptRelevanceReference
"The cause of hyperkalemia is frequently iatrogenic."1.72[Hyperkalemia due to low-molecular-weight heparin]. ( Appelman-Dijkstra, NM; den Exter, PL; Koopman, JJEB; van der Heiden, W, 2022)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
van der Heiden, W1
Koopman, JJEB1
Appelman-Dijkstra, NM1
den Exter, PL1

Other Studies

1 other study available for dalteparin and Acidosis, Renal Tubular Type IV

ArticleYear
[Hyperkalemia due to low-molecular-weight heparin].
    Nederlands tijdschrift voor geneeskunde, 2022, 06-20, Volume: 166

    Topics: Anticoagulants; Heparin; Heparin, Low-Molecular-Weight; Humans; Hyperkalemia; Hypoaldosteronism; Mal

2022